Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Stock
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
-1.38M
-
Total reported value, excl. options
-
$28.9M
-
Value change
-
-$2.4M
-
Number of buys
-
12
-
Number of sells
-
-22
-
Price
-
$2.00
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2019
45 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q3 2019.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
.
Largest 10 shareholders include BVF INC/IL (2.69M shares), Bellevue Group AG (2.3M shares), Omega Fund Management, LLC (1.64M shares), INTERWEST VENTURE MANAGEMENT CO (1.36M shares), FRAZIER MANAGEMENT LLC (1.31M shares), Aisling Capital LLC (892K shares), VANGUARD GROUP INC (679K shares), RENAISSANCE TECHNOLOGIES LLC (676K shares), ALETHEA CAPITAL MANAGEMENT, LLC (564K shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (464K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.